Evidence map›Paper›PMID 32406612›Full record

ArticleESC heart failure2020

Echocardiographic assessment of insulin-like growth factor binding protein-7 and early identification of acute heart failure.

Arzu Kalayci, W Frank Peacock, John T Nagurney, Judd E Hollander, Phillip D Levy, Adam J Singer, Nathan I Shapiro, Richard K Cheng, Chad M Cannon, Andra L Blomkalns and 11 more

Open access · goldAbstract read
In one paragraph

Article in ESC heart failure, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 19 institutions in 4 countries.

Arzu KalayciBaim Institute for Clinical Research, Boston, MA, USA.
W Frank PeacockDepartment of Emergency Medicine, Baylor College of Medicine, Houston, TX, USA.
John T NagurneyDepartment of Emergency Medicine, Massachusetts General Hospital, Boston, MA, USA.
Judd E HollanderDepartment of Emergency Medicine, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
Phillip D LevyDepartment of Emergency Medicine and Integrative Biosciences Center, Wayne State University, Detroit, MI, USA.
Adam J SingerDepartment of Emergency Medicine, Stony Brook University Hospital, Stony Brook, NY, USA.
Nathan I ShapiroDepartment of Emergency Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Richard K ChengDivision of Cardiology, University of Washington, Seattle, WA, USA.
Chad M CannonDepartment of Emergency Medicine, University of Kansas Medical Center, Kansas City, KS, USA.
Andra L BlomkalnsDepartment of Emergency Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Elizabeth L WaltersDepartment of Emergency Medicine, Loma Linda University Medical Center, Loma Linda, CA, USA.
Robert H ChristensonDepartment of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.
Annabel Chen-TournouxDivision of Cardiology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
Richard M NowakDepartment of Emergency Medicine, Henry Ford Health System, Detroit, MI, USA.
Mark D LurieDivision of Cardiology, Torrance Memorial Medical Center, Torrance, CA, USA.
Peter S PangDepartment of Emergency Medicine, Indiana University School of Medicine & Indianapolis EMS, Indianapolis, Indiana, USA.
Peter KastnerRoche Diagnostics GmbH, Penzberg, Germany.
Serge MassonRoche Diagnostics International, Rotkreuz, Switzerland.
C Michael GibsonBaim Institute for Clinical Research, Boston, MA, USA.
Hanna K GagginDivision of Cardiology, Department of Medicine, Massachusetts General Hospital, Yawkey 5984, 55 Fruit Street, Boston, MA, 02114, USA.
James L JanuzziBaim Institute for Clinical Research, Boston, MA, USA.
Harvard University · USMassachusetts General Hospital · USBaim Institute for Clinical Research · USBaylor College of Medicine · USBeth Israel Deaconess Medical Center · USHenry Ford Health System · USIndiana University – Purdue University Indianapolis · USLoma Linda University · USMcGill University · CARoche (Switzerland) · CHRotary International · USStanford Medicine · USStony Brook University Hospital · USThomas Jefferson University Hospital · USTorrance Memorial Medical Center · USUniversity of Kansas Medical Center · USUniversity of Maryland, Baltimore · USUniversity of Washington · USWayne State University · US

Funding

Hutter Family ProfessorshipRocheRoche Diagnostics
6 · The paper itself

Abstract

aimsConcentrations of insulin-like growth factor binding protein-7 (IGFBP7) have been linked to abnormal cardiac structure and function in patients with chronic heart failure (HF), but cardiovascular correlates of the biomarker in patients with more acute presentations are lacking. We aimed to determine the relationship between IGFBP7 concentrations and cardiac structure and to evaluate the impact of IGFBP7 on the diagnosis of acute HF among patients with acute dyspnoea. METHODS AND

resultsIn this pre-specified subgroup analysis of the International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department (ICON-RELOADED) study, we included 271 patients with and without acute HF. All patients presented to an emergency department with acute dyspnoea, had blood samples for IGFBP7 measurement, and detailed echocardiographic evaluation. Higher IGFBP7 concentrations were associated with numerous cardiac abnormalities, including increased left atrial volume index (LAVi; r = 0.49, P < 0.001), lower left ventricular ejection fraction (r = -0.27, P < 0.001), lower right ventricular fractional area change (r = -0.31, P < 0.001), and higher tissue Doppler E/e' ratio (r = 0.44, P < 0.001). In multivariable linear regression analyses, increased LAVi (P = 0.01), lower estimated glomerular filtration rate (P = 0.008), higher body mass index (P = 0.001), diabetes (P = 0.009), and higher concentrations of amino-terminal pro-B-type natriuretic peptide (NT-proBNP, P = 0.02) were independently associated with higher IGFBP7 concentrations regardless of other variables. Furthermore, IGFBP7 (odds ratio = 12.08, 95% confidence interval 2.42-60.15, P = 0.02) was found to be independently associated with the diagnosis of acute HF in the multivariable logistic regression analysis.

conclusionsAmong acute dyspnoeic patients with and without acute HF, increased IGFBP7 concentrations are associated with a range of cardiac structure and function abnormalities. Independent association with increased LAVi suggests elevated left ventricular filling pressure is an important trigger for IGFBP7 expression and release. IGFBP7 may enhance the diagnosis of acute HF.

Indexed as

Heart FailureVentricular Function, LeftEchocardiographyHumansInsulin-Like Growth Factor Binding ProteinsStroke Volumeinsulin-like growth factor binding protein-related protein 1Insulin-Like Growth Factor Binding ProteinsAcute heart failureDyspnoeaEchocardiographyIGFBP7

Identifiers

PMID32406612
PMCPMC7373911
OpenAlexW3025513698

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.